Parallel Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
27
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$20M
- Investors
-
24
Parallel Bio General Information
Description
Developer of a drug development platform designed to evaluate the efficacy and safety of immunotherapies. The company's platform utilizes a framework combining human lymph-node immune organoids, automated robotics, and artificial intelligence, enabling medical professionals to conduct population-scale testing, model diverse patient backgrounds, and accelerate candidate drug pipelines without traditional animal testing.
Contact Information
Website
www.parallel.bioCorporate Office
- 1000 Marina Boulevard
- Suite 105
- Brisbane, CA 94005
- United States
Corporate Office
- 1000 Marina Boulevard
- Suite 105
- Brisbane, CA 94005
- United States
Parallel Bio Timeline
Parallel Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A1) | 12-Jun-2025 | $20M | Completed | Generating Revenue | ||
| 3. Seed Round | 20-Dec-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 07-Jul-2021 | $325K | $325K | Completed | Startup | |
| 1. Accelerator/Incubator | 01-Jan-2021 | Completed | Startup |
Parallel Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A-4 | ||||||||
| Series A-3 | 439,752 | $0.000100 | 8% | $0.45 | $0.45 | 1x | $0.45 | 1.57% |
| Series A-2 | 1,231,342 | $0.000100 | 8% | $0.1 | $0.1 | 1x | $0.1 | 4.38% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Parallel Bio Comparisons
Industry
Financing
Details
Parallel Bio Competitors (2)
One of Parallel Bio’s 2 competitors is ImmunityBio, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ImmunityBio | Formerly VC-backed | San Diego, CA | ||||
| Atara Biotherapeutics | Formerly VC-backed | Thousand Oaks, CA |
Parallel Bio Patents
Parallel Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025155725-A1 | Methods of using immune organoids to predict drug efficacy | Pending | 17-Jan-2024 | ||
| WO-2025155727-A1 | Methods of using immune organoids to predict drug safety | Pending | 17-Jan-2024 | ||
| US-11913967-B2 | System and method for determining dispensing volume for a liquid handler | Active | 22-Jul-2022 | ||
| US-12265097-B2 | System and method for determining dispensing volume for a liquid handler | Active | 22-Jul-2022 | ||
| US-20240027486-A1 | System and method for determining dispensing volume for a liquid handler | Active | 22-Jul-2022 | G01N35/1016 |
Parallel Bio Signals
Parallel Bio Investors (24)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AIX Ventures | Venture Capital | Minority | ||
| Amplo | Venture Capital | Minority | ||
| Autopilot Fund | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| 10X Capital | Venture Capital | Minority |
Parallel Bio FAQs
-
When was Parallel Bio founded?
Parallel Bio was founded in 2021.
-
Where is Parallel Bio headquartered?
Parallel Bio is headquartered in Brisbane, CA.
-
What is the size of Parallel Bio?
Parallel Bio has 27 total employees.
-
What industry is Parallel Bio in?
Parallel Bio’s primary industry is Drug Discovery.
-
Is Parallel Bio a private or public company?
Parallel Bio is a Private company.
-
What is the current valuation of Parallel Bio?
The current valuation of Parallel Bio is .
-
What is Parallel Bio’s current revenue?
The current revenue for Parallel Bio is .
-
How much funding has Parallel Bio raised over time?
Parallel Bio has raised $24.6M.
-
Who are Parallel Bio’s investors?
AIX Ventures, Amplo, Autopilot Fund, , and 10X Capital are 5 of 24 investors who have invested in Parallel Bio.
-
Who are Parallel Bio’s competitors?
ImmunityBio and Atara Biotherapeutics are competitors of Parallel Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process